東京大学医学系研究科 国際保健政策学 東京大学 The University of Tokyo

Department of Global Health Policy

Graduate School of Medicine, The University of Tokyo

Global Burden of Disease

世界の疾病負担研究

死や病気の原因やそれらの影響について地球規模で理解することは、
国家、国家間レベルでの政策決定やプログラム評価にとって不可欠である。
この研究の世界のリーダーであるワシントン大学のInstitute for Health Metric Evaluation と協力し、
国家・地球レベルでの病気がもたらす負担について、正確で最新の計測を行い、
また方法論の改善を行っている。

Understanding the extent and causes of death and disease at a global level is essential
for priority setting and program evaluation nationally and internationally.
The key driver of this complex and challenging task is the Institute
for Health Metric Evaluation (IHME) at the University of Washington.
The Department of Global Health Policy collaborates closely
with the IHME to generate accurate, up-to-date burden of disease assessments
at the national and global level, and to improve the sophisticated methodologies underlying this process.

研究員 Researchers:Kenji Shibuya, Nayu Ikeda 渋谷健司池田奈由
研究トピック Research Topics: Health Outcomes Research 

Recent Publications

GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1345-1422.

Read the Article →

GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1260–1344.

Read the Article →

GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1151–1210.

Read the Article →

GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1084–1150.

Read the Article →

GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1423–59.

Read the Article →

Nomura S, Sakamoto H, Glenn S, Tsugawa Y, Abe SK, Rahman MM, Brown JC, Ezoe S, Fitzmaurice C, Inokuchi T, Kassebaum NJ, Kawakami N, Kita Y, Kondo N, Lim SS, Maruyama S, Miyata H, Mooney MD, Naghavi M, Onoda T, Erika O, Otake Y, Roth GA, Saito E, Tabuchi T, Takasaki Y, Taimura T, Uechi M, Vos T, Wang H, Inoue M, Murray CJL, Shibuya K. Population health and regional variations of disease burden in Japan, 1990–2015: a systematic subnational analysis for the Global Burden of Disease Study 2015. The Lancet. 2017; Online first.

Read the Article →

Kita Sugai M, Gilmour S, Ota E, Shibuya K. Trends in perinatal mortality and its risk factors in Japan: Analysis of vital registration data, 1979–2010. Scientific Reports. 2017; 46681.

Read the Article →

Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Annals of Epidemiology. Online first.

Read the Article →

GBD 2015 HIV Collaborators. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. The Lancet HIV. 2016;3(8): e361-e387.

Read the Article →

GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053): 1775-1812.

Read the Article →

GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053): 1725-1774.

Read the Article →

GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1659-1724.

Read the Article →

GBD 2015 DALYS and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1603-1658.

Read the Article →

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1545-1602.

Read the Article →

GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016; 388(10053): 1459-1544.

Read the Article →